We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Diamondback Energy
FANG
$55.1B
| $634K | ﹤0.01% |
6,752
| – | – |
|
|
LAC
752
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $630K | ﹤0.01% |
42,463
+21,463
| +102% | +$307K |
|
753
Treace Medical Concepts
TMCI
$265M
| $625K | ﹤0.01% |
+20,000
| New | +$637K |
|
|
CMA
754
DELISTED
Comerica
CMA
| $621K | ﹤0.01% |
8,711
-3,705
| -30% | -$275K |
|
755
News Corp Class A
NWSA
$14.8B
| $611K | ﹤0.01% |
+23,724
| New | +$626K |
|
756
Lemonade
LMND
$4.76B
| $602K | ﹤0.01% |
5,500
| – | – |
|
757
CF Industries
CF
$18.4B
| $597K | ﹤0.01% |
11,604
-51,265
| -82% | -$2.61M |
|
758
Lyft
LYFT
$5.73B
| $591K | ﹤0.01% |
9,772
+1,479
| +18% | +$85.1K |
|
|
RDHL
759
Redhill Biopharma
RDHL
$4.26M
| $568K | ﹤0.01% |
83
| – | – |
|
760
National Fuel Gas
NFG
$7.67B
| $561K | ﹤0.01% |
10,738
-220
| -2% | -$11.4K |
|
761
Boston Beer
SAM
$1.91B
| $551K | ﹤0.01% |
+540
| New | +$606K |
|
|
EPZM
762
DELISTED
Epizyme, Inc
EPZM
| $551K | ﹤0.01% |
66,329
-39,561
| -37% | -$334K |
|
763
W.R. Berkley
WRB
$28.1B
| $528K | ﹤0.01% |
+15,957
| New | +$552K |
|
|
DISH
764
DELISTED
DISH Network Corp.
DISH
| $515K | ﹤0.01% |
+12,321
| New | +$518K |
|
765
Fox Class A
FOXA
$23.8B
| $504K | ﹤0.01% |
13,565
+3,186
| +31% | +$120K |
|
766
Global X Copper Miners ETF NEW
COPX
$7.2B
| $503K | ﹤0.01% |
+13,550
| New | +$535K |
|
767
iShares Global Clean Energy ETF
ICLN
$2.35B
| $497K | ﹤0.01% |
21,200
+13,800
| +186% | +$315K |
|
768
Telus
TU
$16.2B
| $488K | ﹤0.01% |
21,734
-348,109
| -94% | -$7.55M |
|
769
Agnico Eagle Mines
AEM
$73B
| $483K | ﹤0.01% |
7,982
+895
| +13% | +$59.7K |
|
770
Pembina Pipeline
PBA
$29B
| $481K | ﹤0.01% |
15,130
-266,848
| -95% | -$8.37M |
|
771
Invesco WilderHill Clean Energy ETF
PBW
$409M
| $431K | ﹤0.01% |
4,620
-480
| -9% | -$41.6K |
|
772
Shinhan Financial Group
SHG
$33.6B
| $430K | ﹤0.01% |
12,000
-6,184
| -34% | -$222K |
|
773
XPeng
XPEV
$12.2B
| $416K | ﹤0.01% |
+9,375
| New | +$320K |
|
774
Huntington Ingalls Industries
HII
$11.4B
| $405K | ﹤0.01% |
1,921
-29,668
| -94% | -$6.32M |
|
|
EAR
775
DELISTED
Eargo, Inc. Common Stock
EAR
| $395K | ﹤0.01% |
495
-1,045
| -68% | -$876K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.